The Pennant Group (NASDAQ:PNTG) Sets New 1-Year High at $20.54

The Pennant Group, Inc. (NASDAQ:PNTGGet Free Report) reached a new 52-week high during trading on Wednesday . The company traded as high as $20.54 and last traded at $20.49, with a volume of 81408 shares changing hands. The stock had previously closed at $20.06.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on PNTG. Stephens raised shares of The Pennant Group from an “equal weight” rating to an “overweight” rating and boosted their price target for the company from $14.00 to $18.00 in a research report on Friday, January 5th. Truist Financial upped their target price on The Pennant Group from $16.00 to $21.00 and gave the company a “hold” rating in a research report on Friday, March 1st. Finally, Oppenheimer lifted their price target on The Pennant Group from $18.00 to $22.00 and gave the stock an “outperform” rating in a research report on Friday, March 1st.

View Our Latest Stock Analysis on The Pennant Group

The Pennant Group Stock Performance

The stock’s 50-day moving average is $17.49 and its 200 day moving average is $14.51. The stock has a market cap of $609.80 million, a price-to-earnings ratio of 45.59, a P/E/G ratio of 2.12 and a beta of 2.06. The company has a debt-to-equity ratio of 0.44, a current ratio of 1.12 and a quick ratio of 1.12.

The Pennant Group (NASDAQ:PNTGGet Free Report) last issued its earnings results on Wednesday, February 28th. The company reported $0.18 EPS for the quarter, missing the consensus estimate of $0.19 by ($0.01). The Pennant Group had a return on equity of 12.78% and a net margin of 2.46%. The company had revenue of $145.95 million for the quarter, compared to analysts’ expectations of $136.79 million. During the same quarter in the previous year, the firm posted $0.15 earnings per share. As a group, analysts predict that The Pennant Group, Inc. will post 0.73 earnings per share for the current fiscal year.

Institutional Trading of The Pennant Group

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in PNTG. Allspring Global Investments Holdings LLC grew its holdings in The Pennant Group by 21.0% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 5,443 shares of the company’s stock valued at $61,000 after buying an additional 944 shares during the period. Captrust Financial Advisors grew its stake in shares of The Pennant Group by 34.8% during the 1st quarter. Captrust Financial Advisors now owns 4,098 shares of the company’s stock valued at $76,000 after buying an additional 1,057 shares during the period. Yousif Capital Management LLC increased its stake in The Pennant Group by 4.6% during the first quarter. Yousif Capital Management LLC now owns 24,711 shares of the company’s stock worth $460,000 after acquiring an additional 1,095 shares during the last quarter. PNC Financial Services Group Inc. grew its holdings in shares of The Pennant Group by 23.0% during the 4th quarter. PNC Financial Services Group Inc. now owns 6,210 shares of the company’s stock worth $68,000 after purchasing an additional 1,162 shares during the period. Finally, UBS Asset Management Americas Inc. raised its holdings in The Pennant Group by 3.9% in the third quarter. UBS Asset Management Americas Inc. now owns 33,699 shares of the company’s stock valued at $351,000 after buying an additional 1,264 shares during the period. Hedge funds and other institutional investors own 85.88% of the company’s stock.

The Pennant Group Company Profile

(Get Free Report)

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.

Featured Articles

Receive News & Ratings for The Pennant Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Pennant Group and related companies with MarketBeat.com's FREE daily email newsletter.